Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Don't Floss, You Lose - (ATRX) To the RESCUE. -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (86)	3/23/1999 9:14:00 AM
From: gcrispin	Read Replies (1) \| Respond to of 182

For the long term it is a positive and a smart move. It also shows that the schools can look at the data with a more objective eye. The two year time frame roughly corresponds to the acceptance cycle for bleaching according to my brother, who is a dentist. He asserts that bleaching was not something that dentists embraced in the beginning. But patients were the ones that demanded it. Now it is standard practice. The key is patience while monitoring continual improvement in sales. I also like the way Atrix is continuing research with phase four trials. These trials will further entrench Atridox as a standard practice in dentistry.